MARKET

RNVEF

RNVEF

Renerve Ltd
EXMKT
--
NaN%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About RNVEF
ReNerve Limited is an Australia-based medical device company developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. It is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, compatible protective wrap used to protect repaired injured nerves. The product is being developed for the surgical repair of transected (cut) and damaged nerves. NervAlign nerve grafts offers surgeons the ability to repair damaged nerves (neurotmesis) without the need to harvest the sural nerve from the patient. It is developing, NervAlign Bionic Nerve, a combination polymer technology and its nerve graft to produce a replacement nerve that contains shaped ionic polymers which would enable the stimulation of the distal end of a nerve injury.

Webull offers ReNerve Ltd stock information, including EXMKT: RNVEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNVEF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNVEF stock methods without spending real money on the virtual paper trading platform.